These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 61918)

  • 21. High HL-A5 frequency in Behçet's disease.
    Nakayama E; Itakura K; Aizawa M
    Hokkaido Igaku Zasshi; 1976 Mar; 51(2):117-21. PubMed ID: 945222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunologic aggregation of human blood platelets and its inhibition in vitro].
    Malberg K; Elendt D; Elendt B
    Allerg Immunol (Leipz); 1986; 32(3):153-67. PubMed ID: 2947439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of an HL-A antiserum by iso-electric focusing.
    Reisner EG; Reisner HM; Chung KS; Folds JD; Amos DB
    J Immunol; 1975 Oct; 115(4):1084-6. PubMed ID: 240883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serologic recognition of histocompatibility antigens using complement fixation.
    Colombani J; Colombani M
    Semin Hematol; 1974 Jul; 11(3):273-80. PubMed ID: 4836675
    [No Abstract]   [Full Text] [Related]  

  • 25. Human platelets as a source of HL-A antigens : a study of various solubilization techniques.
    Dautigny A; Bernier I; Colombani J; Jollès P
    Biochimie; 1975; 57(10):1197-201. PubMed ID: 1222125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HLA compatibility and survival of 51 chromium-labeled allogeneic thrombocytes].
    Májský A; Fortýnová J; Vopatová M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):831-7. PubMed ID: 6176508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Transfusion reactions due to HL-A-specific antilymphocytic and antithrombocytic antibodies].
    Heinrich D; Escolar J; Mueller-Eckhardt C
    Verh Dtsch Ges Inn Med; 1971; 77():1135-8. PubMed ID: 5155978
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphocytotoxines frequency and HL-A typing in "small for date" children.
    Kobielowa Z; Turowski G; Pietrzyk J
    Pol Med Sci Hist Bull (1973); 1975; 15(1):75-9. PubMed ID: 1223808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HL-A in connection with blood transfusion.
    Engelfriet CP; van Loghem JJ
    Haematologia (Budap); 1974; 8(1-4):267-72. PubMed ID: 4618231
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study of the HL-A system; significance and practical methods].
    Crouzet J
    Rev Infirm; 1976 Dec; 26(10):895-8. PubMed ID: 1050805
    [No Abstract]   [Full Text] [Related]  

  • 31. [Incidence of anti-HL-A antibodies in patients under dialysis and in a transplantation program in relation to rejection].
    Erbenová E; Erben J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1976; 19(3):303-9. PubMed ID: 801077
    [No Abstract]   [Full Text] [Related]  

  • 32. [Histocompatibility (HL-A) antigens in regional enteritis and ulcerative colitis].
    Eckhardt R; Freudenberg J; Meyer zum Büschenfelde KH; Berger J
    Verh Dtsch Ges Inn Med; 1975; 81():1292-3. PubMed ID: 1229468
    [No Abstract]   [Full Text] [Related]  

  • 33. Expression of HLA-B12 on platelets, on lymphocytes and in serum: a quantitative study.
    Liebert M; Aster RH
    Tissue Antigens; 1977 Apr; 9(4):199-208. PubMed ID: 69335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical evaluation of HL-A phenotype and genotype frequencies in a large German population determined by platelet complement fixation and lymphocytotoxicity.
    Mueller-Eckhardt C; Heinrich D; Mersch-Baumert K; Czitrom A; Walker P
    Humangenetik; 1974; 24(4):319-24. PubMed ID: 4442875
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of two sources of soluble HL-A antigens: platelets and serum.
    Pellegrino MA; Ferrone S; Pellegrino AG; Oh SK; Reisfeld RA
    Eur J Immunol; 1974 Apr; 4(4):250-5. PubMed ID: 4851933
    [No Abstract]   [Full Text] [Related]  

  • 36. Cryopreserving HLA-typed platelets obtained on cell separators.
    Herve P; Masse M; Coffe C; Peters A
    Lancet; 1977 Jul; 2(8027):45. PubMed ID: 69136
    [No Abstract]   [Full Text] [Related]  

  • 37. [HL-A specific, C'-fixing antithrombocyte antibodies].
    Mueller-Eckhardt C; Heinrich D; Escolar J; Götze U
    Blut; 1971 Oct; 23(4):207-15. PubMed ID: 5123213
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of formalinized thrombocytes as antigens for the demonstration of thrombocyte antibodies by means of the agglutination test, the complement fixation reaction and the anti-human globulin deviation method].
    MAJSKY A; ZIKOVA R
    Z Gesamte Inn Med; 1960 Dec; 15():1117-22. PubMed ID: 13765565
    [No Abstract]   [Full Text] [Related]  

  • 39. [Demonstration of blood group antigens in thrombocytes].
    MEYER W; WUILLERET B; HASSIG A
    Z Immun exp ther; 1955 Dec; 112(5-6):368-72. PubMed ID: 13312438
    [No Abstract]   [Full Text] [Related]  

  • 40. [New contribution to the study of blood group antigens in thrombocytes. I. Demonstration of Fya factor in blood platelets].
    DUCOS J
    Sangre (Barc); 1959; 30():644-50. PubMed ID: 13818420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.